APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lysosomal Alpha Glucosidase

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lysosomal Alpha Glucosidase Market Outlook and Growth Opportunities 2026

19 December 2025191 pages

Choose your research edition.

Industry ResearchLysosomal Alpha Glucosidase Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Lysosomal Alpha Glucosidase Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Lysosomal Alpha Glucosidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lysosomal Alpha Glucosidase Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lysosomal Alpha Glucosidase Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Lysosomal Alpha Glucosidase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lysosomal Alpha Glucosidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lysosomal Alpha Glucosidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lysosomal Alpha Glucosidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lysosomal Alpha Glucosidase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lysosomal Alpha Glucosidase market include Sarepta Therapeutics Inc, Pharming Group NV, Oxyrane Belgium NV, JCR Pharmaceuticals Co Ltd, Huons Co Ltd, greenovation Biotech GmbH, Genzyme Corp, Etubics Corp and Audentes Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lysosomal Alpha Glucosidase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lysosomal Alpha Glucosidase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lysosomal Alpha Glucosidase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lysosomal Alpha Glucosidase market size, projected growth trends, production technologies, key applications, and end-use industries.

Lysosomal Alpha Glucosidase Segment by Company

Sarepta Therapeutics Inc

Pharming Group NV

Oxyrane Belgium NV

JCR Pharmaceuticals Co Ltd

Huons Co Ltd

greenovation Biotech GmbH

Genzyme Corp

Etubics Corp

Audentes Therapeutics Inc

Amicus Therapeutics Inc

Lysosomal Alpha Glucosidase Segment by Type

AT-982

ATB-200

AVRRD-03

JR-162

MOSS-GAA

OXY-2810

Others

Lysosomal Alpha Glucosidase Segment by Application

Glycogen Storage Disease

Pompe Disease

Others

Lysosomal Alpha Glucosidase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Lysosomal Alpha Glucosidase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lysosomal Alpha Glucosidase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lysosomal Alpha Glucosidase significant trends, drivers, influence factors in global and regions.

6. To analyze Lysosomal Alpha Glucosidase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lysosomal Alpha Glucosidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lysosomal Alpha Glucosidase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lysosomal Alpha Glucosidase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lysosomal Alpha Glucosidase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lysosomal Alpha Glucosidase industry.

Chapter 3: Detailed analysis of Lysosomal Alpha Glucosidase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lysosomal Alpha Glucosidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lysosomal Alpha Glucosidase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lysosomal Alpha Glucosidase Industry Trends Table 2. Lysosomal Alpha Glucosidase Industry Drivers Table 3. Lysosomal Alpha Glucosidase Industry Opportunities and Challenges Table 4. Lysosomal Alpha Glucosidase Industry Restraints Table 5. Global Lysosomal Alpha Glucosidase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lysosomal Alpha Glucosidase Revenue Share by Company (2021-2026) Table 7. Global Lysosomal Alpha Glucosidase Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Lysosomal Alpha Glucosidase Sales Volume Share by Company (2021-2026) Table 9. Global Lysosomal Alpha Glucosidase Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lysosomal Alpha Glucosidase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lysosomal Alpha Glucosidase Key Company Manufacturing Base & Headquarters Table 12. Global Lysosomal Alpha Glucosidase Company, Product Type & Application Table 13. Global Lysosomal Alpha Glucosidase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lysosomal Alpha Glucosidase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of AT-982 Table 18. Significant Companies of ATB-200 Table 19. Significant Companies of AVRRD-03 Table 20. Significant Companies of JR-162 Table 21. Significant Companies of MOSS-GAA Table 22. Significant Companies of OXY-2810 Table 23. Significant Companies of Others Table 24. Global Lysosomal Alpha Glucosidase Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Lysosomal Alpha Glucosidase Sales Volume by Type (2021-2026) & (K Units) Table 26. Global Lysosomal Alpha Glucosidase Sales Volume by Type (2027-2032) & (K Units) Table 27. Global Lysosomal Alpha Glucosidase Sales Volume Share by Type (2021-2026) Table 28. Global Lysosomal Alpha Glucosidase Sales Volume Share by Type (2027-2032) Table 29. Global Lysosomal Alpha Glucosidase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Lysosomal Alpha Glucosidase Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global Lysosomal Alpha Glucosidase Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global Lysosomal Alpha Glucosidase Sales Value Share by Type (2021-2026) Table 33. Global Lysosomal Alpha Glucosidase Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Glycogen Storage Disease Table 35. Significant Companies of Pompe Disease Table 36. Significant Companies of Others Table 37. Global Lysosomal Alpha Glucosidase Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Lysosomal Alpha Glucosidase Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Lysosomal Alpha Glucosidase Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Lysosomal Alpha Glucosidase Sales Volume Share by Application (2021-2026) Table 41. Global Lysosomal Alpha Glucosidase Sales Volume Share by Application (2027-2032) Table 42. Global Lysosomal Alpha Glucosidase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Lysosomal Alpha Glucosidase Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Lysosomal Alpha Glucosidase Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Lysosomal Alpha Glucosidase Sales Value Share by Application (2021-2026) Table 46. Global Lysosomal Alpha Glucosidase Sales Value Share by Application (2027-2032) Table 47. Global Lysosomal Alpha Glucosidase Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Lysosomal Alpha Glucosidase Sales by Region (2021-2026) & (K Units) Table 49. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2021-2026) Table 50. Global Lysosomal Alpha Glucosidase Sales by Region (2027-2032) & (K Units) Table 51. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2027-2032) Table 52. Global Lysosomal Alpha Glucosidase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Lysosomal Alpha Glucosidase Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Lysosomal Alpha Glucosidase Sales Value Share by Region (2021-2026) Table 55. Global Lysosomal Alpha Glucosidase Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Lysosomal Alpha Glucosidase Sales Value Share by Region (2027-2032) Table 57. Global Lysosomal Alpha Glucosidase Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Lysosomal Alpha Glucosidase Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Lysosomal Alpha Glucosidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Lysosomal Alpha Glucosidase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 62. Global Lysosomal Alpha Glucosidase Sales Market Share by Country (2021-2026) Table 63. Global Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 64. Global Lysosomal Alpha Glucosidase Sales Market Share by Country (2027-2032) Table 65. Global Lysosomal Alpha Glucosidase Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Lysosomal Alpha Glucosidase Sales Value Market Share by Country (2021-2026) Table 67. Global Lysosomal Alpha Glucosidase Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Lysosomal Alpha Glucosidase Sales Value Market Share by Country (2027-2032) Table 69. Sarepta Therapeutics Inc Company Information Table 70. Sarepta Therapeutics Inc Business Overview Table 71. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio Table 73. Sarepta Therapeutics Inc Recent Development Table 74. Pharming Group NV Company Information Table 75. Pharming Group NV Business Overview Table 76. Pharming Group NV Lysosomal Alpha Glucosidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Pharming Group NV Lysosomal Alpha Glucosidase Product Portfolio Table 78. Pharming Group NV Recent Development Table 79. Oxyrane Belgium NV Company Information Table 80. Oxyrane Belgium NV Business Overview Table 81. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Portfolio Table 83. Oxyrane Belgium NV Recent Development Table 84. JCR Pharmaceuticals Co Ltd Company Information Table 85. JCR Pharmaceuticals Co Ltd Business Overview Table 86. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Portfolio Table 88. JCR Pharmaceuticals Co Ltd Recent Development Table 89. Huons Co Ltd Company Information Table 90. Huons Co Ltd Business Overview Table 91. Huons Co Ltd Lysosomal Alpha Glucosidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Huons Co Ltd Lysosomal Alpha Glucosidase Product Portfolio Table 93. Huons Co Ltd Recent Development Table 94. greenovation Biotech GmbH Company Information Table 95. greenovation Biotech GmbH Business Overview Table 96. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Portfolio Table 98. greenovation Biotech GmbH Recent Development Table 99. Genzyme Corp Company Information Table 100. Genzyme Corp Business Overview Table 101. Genzyme Corp Lysosomal Alpha Glucosidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Genzyme Corp Lysosomal Alpha Glucosidase Product Portfolio Table 103. Genzyme Corp Recent Development Table 104. Etubics Corp Company Information Table 105. Etubics Corp Business Overview Table 106. Etubics Corp Lysosomal Alpha Glucosidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Etubics Corp Lysosomal Alpha Glucosidase Product Portfolio Table 108. Etubics Corp Recent Development Table 109. Audentes Therapeutics Inc Company Information Table 110. Audentes Therapeutics Inc Business Overview Table 111. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio Table 113. Audentes Therapeutics Inc Recent Development Table 114. Amicus Therapeutics Inc Company Information Table 115. Amicus Therapeutics Inc Business Overview Table 116. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio Table 118. Amicus Therapeutics Inc Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Lysosomal Alpha Glucosidase Distributors List Table 122. Lysosomal Alpha Glucosidase Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Lysosomal Alpha Glucosidase Product Image Figure 2. Global Lysosomal Alpha Glucosidase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lysosomal Alpha Glucosidase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lysosomal Alpha Glucosidase Sales (2021-2032) & (K Units) Figure 5. Global Lysosomal Alpha Glucosidase Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lysosomal Alpha Glucosidase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. AT-982 Image Figure 10. ATB-200 Image Figure 11. AVRRD-03 Image Figure 12. JR-162 Image Figure 13. MOSS-GAA Image Figure 14. OXY-2810 Image Figure 15. Others Image Figure 16. Global Lysosomal Alpha Glucosidase Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Lysosomal Alpha Glucosidase Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global Lysosomal Alpha Glucosidase Sales Volume Share by Type (2021-2032) Figure 19. Global Lysosomal Alpha Glucosidase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Lysosomal Alpha Glucosidase Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Lysosomal Alpha Glucosidase Sales Value Share by Type (2021-2032) Figure 22. Glycogen Storage Disease Image Figure 23. Pompe Disease Image Figure 24. Others Image Figure 25. Global Lysosomal Alpha Glucosidase Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Lysosomal Alpha Glucosidase Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Lysosomal Alpha Glucosidase Sales Volume Share by Application (2021-2032) Figure 28. Global Lysosomal Alpha Glucosidase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Lysosomal Alpha Glucosidase Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Lysosomal Alpha Glucosidase Sales Value Share by Application (2021-2032) Figure 31. Global Lysosomal Alpha Glucosidase Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Lysosomal Alpha Glucosidase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Lysosomal Alpha Glucosidase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Lysosomal Alpha Glucosidase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Lysosomal Alpha Glucosidase Sales Value (2021-2032) & (US$ Million) Figure 36. North America Lysosomal Alpha Glucosidase Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Lysosomal Alpha Glucosidase Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Lysosomal Alpha Glucosidase Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Lysosomal Alpha Glucosidase Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Lysosomal Alpha Glucosidase Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Lysosomal Alpha Glucosidase Sales Value (2021-2032) & (US$ Million) Figure 42. South America Lysosomal Alpha Glucosidase Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Lysosomal Alpha Glucosidase Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Lysosomal Alpha Glucosidase Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Lysosomal Alpha Glucosidase Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Lysosomal Alpha Glucosidase Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • AT-982
  • ATB-200
  • AVRRD-03
  • JR-162
  • MOSS-GAA
  • OXY-2810
  • Others
Applications
  • Glycogen Storage Disease
  • Pompe Disease
  • Others
Companies covered
  • Sarepta Therapeutics Inc
  • Pharming Group NV
  • Oxyrane Belgium NV
  • JCR Pharmaceuticals Co Ltd
  • Huons Co Ltd
  • greenovation Biotech GmbH
  • Genzyme Corp
  • Etubics Corp
  • Audentes Therapeutics Inc
  • Amicus Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lysosomal Alpha Glucosidase Sales Value (2021-2032)
  4. 1.2.2 Global Lysosomal Alpha Glucosidase Sales Volume (2021-2032)
  5. 1.2.3 Global Lysosomal Alpha Glucosidase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lysosomal Alpha Glucosidase Market Dynamics
  1. 2.1 Lysosomal Alpha Glucosidase Industry Trends
  2. 2.2 Lysosomal Alpha Glucosidase Industry Drivers
  3. 2.3 Lysosomal Alpha Glucosidase Industry Opportunities and Challenges
  4. 2.4 Lysosomal Alpha Glucosidase Industry Restraints
3 Lysosomal Alpha Glucosidase Market by Company
  1. 3.1 Global Lysosomal Alpha Glucosidase Company Revenue Ranking in 2025
  2. 3.2 Global Lysosomal Alpha Glucosidase Revenue by Company (2021-2026)
  3. 3.3 Global Lysosomal Alpha Glucosidase Sales Volume by Company (2021-2026)
  4. 3.4 Global Lysosomal Alpha Glucosidase Average Price by Company (2021-2026)
  5. 3.5 Global Lysosomal Alpha Glucosidase Company Ranking (2024-2026)
  6. 3.6 Global Lysosomal Alpha Glucosidase Company Manufacturing Base and Headquarters
  7. 3.7 Global Lysosomal Alpha Glucosidase Company Product Type and Application
  8. 3.8 Global Lysosomal Alpha Glucosidase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lysosomal Alpha Glucosidase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lysosomal Alpha Glucosidase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lysosomal Alpha Glucosidase Market by Type
  1. 4.1 Lysosomal Alpha Glucosidase Type Introduction
  2. 4.1.1 AT-982
  3. 4.1.2 ATB-200
  4. 4.1.3 AVRRD-03
  5. 4.1.4 JR-162
  6. 4.1.5 MOSS-GAA
  7. 4.1.6 OXY-2810
  8. 4.1.7 Others
  9. 4.2 Global Lysosomal Alpha Glucosidase Sales Volume by Type
  10. 4.2.1 Global Lysosomal Alpha Glucosidase Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Lysosomal Alpha Glucosidase Sales Volume by Type (2021-2032)
  12. 4.2.3 Global Lysosomal Alpha Glucosidase Sales Volume Share by Type (2021-2032)
  13. 4.3 Global Lysosomal Alpha Glucosidase Sales Value by Type
  14. 4.3.1 Global Lysosomal Alpha Glucosidase Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Lysosomal Alpha Glucosidase Sales Value by Type (2021-2032)
  16. 4.3.3 Global Lysosomal Alpha Glucosidase Sales Value Share by Type (2021-2032)
5 Lysosomal Alpha Glucosidase Market by Application
  1. 5.1 Lysosomal Alpha Glucosidase Application Introduction
  2. 5.1.1 Glycogen Storage Disease
  3. 5.1.2 Pompe Disease
  4. 5.1.3 Others
  5. 5.2 Global Lysosomal Alpha Glucosidase Sales Volume by Application
  6. 5.2.1 Global Lysosomal Alpha Glucosidase Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lysosomal Alpha Glucosidase Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lysosomal Alpha Glucosidase Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lysosomal Alpha Glucosidase Sales Value by Application
  10. 5.3.1 Global Lysosomal Alpha Glucosidase Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lysosomal Alpha Glucosidase Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lysosomal Alpha Glucosidase Sales Value Share by Application (2021-2032)
6 Lysosomal Alpha Glucosidase Regional Sales and Value Analysis
  1. 6.1 Global Lysosomal Alpha Glucosidase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lysosomal Alpha Glucosidase Sales by Region (2021-2032)
  3. 6.2.1 Global Lysosomal Alpha Glucosidase Sales by Region: 2021-2026
  4. 6.2.2 Global Lysosomal Alpha Glucosidase Sales by Region (2027-2032)
  5. 6.3 Global Lysosomal Alpha Glucosidase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lysosomal Alpha Glucosidase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lysosomal Alpha Glucosidase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lysosomal Alpha Glucosidase Sales Value by Region (2027-2032)
  9. 6.5 Global Lysosomal Alpha Glucosidase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lysosomal Alpha Glucosidase Sales Value (2021-2032)
  12. 6.6.2 North America Lysosomal Alpha Glucosidase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lysosomal Alpha Glucosidase Sales Value (2021-2032)
  15. 6.7.2 Europe Lysosomal Alpha Glucosidase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lysosomal Alpha Glucosidase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lysosomal Alpha Glucosidase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lysosomal Alpha Glucosidase Sales Value (2021-2032)
  21. 6.9.2 South America Lysosomal Alpha Glucosidase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lysosomal Alpha Glucosidase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lysosomal Alpha Glucosidase Sales Value Share by Country, 2025 VS 2032
7 Lysosomal Alpha Glucosidase Country-level Sales and Value Analysis
  1. 7.1 Global Lysosomal Alpha Glucosidase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lysosomal Alpha Glucosidase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lysosomal Alpha Glucosidase Sales by Country (2021-2032)
  4. 7.3.1 Global Lysosomal Alpha Glucosidase Sales by Country (2021-2026)
  5. 7.3.2 Global Lysosomal Alpha Glucosidase Sales by Country (2027-2032)
  6. 7.4 Global Lysosomal Alpha Glucosidase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lysosomal Alpha Glucosidase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lysosomal Alpha Glucosidase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lysosomal Alpha Glucosidase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lysosomal Alpha Glucosidase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lysosomal Alpha Glucosidase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sarepta Therapeutics Inc
  2. 8.1.1 Sarepta Therapeutics Inc Company Information
  3. 8.1.2 Sarepta Therapeutics Inc Business Overview
  4. 8.1.3 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
  6. 8.1.5 Sarepta Therapeutics Inc Recent Developments
  7. 8.2 Pharming Group NV
  8. 8.2.1 Pharming Group NV Company Information
  9. 8.2.2 Pharming Group NV Business Overview
  10. 8.2.3 Pharming Group NV Lysosomal Alpha Glucosidase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pharming Group NV Lysosomal Alpha Glucosidase Product Portfolio
  12. 8.2.5 Pharming Group NV Recent Developments
  13. 8.3 Oxyrane Belgium NV
  14. 8.3.1 Oxyrane Belgium NV Company Information
  15. 8.3.2 Oxyrane Belgium NV Business Overview
  16. 8.3.3 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Portfolio
  18. 8.3.5 Oxyrane Belgium NV Recent Developments
  19. 8.4 JCR Pharmaceuticals Co Ltd
  20. 8.4.1 JCR Pharmaceuticals Co Ltd Company Information
  21. 8.4.2 JCR Pharmaceuticals Co Ltd Business Overview
  22. 8.4.3 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Portfolio
  24. 8.4.5 JCR Pharmaceuticals Co Ltd Recent Developments
  25. 8.5 Huons Co Ltd
  26. 8.5.1 Huons Co Ltd Company Information
  27. 8.5.2 Huons Co Ltd Business Overview
  28. 8.5.3 Huons Co Ltd Lysosomal Alpha Glucosidase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Huons Co Ltd Lysosomal Alpha Glucosidase Product Portfolio
  30. 8.5.5 Huons Co Ltd Recent Developments
  31. 8.6 greenovation Biotech GmbH
  32. 8.6.1 greenovation Biotech GmbH Company Information
  33. 8.6.2 greenovation Biotech GmbH Business Overview
  34. 8.6.3 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Portfolio
  36. 8.6.5 greenovation Biotech GmbH Recent Developments
  37. 8.7 Genzyme Corp
  38. 8.7.1 Genzyme Corp Company Information
  39. 8.7.2 Genzyme Corp Business Overview
  40. 8.7.3 Genzyme Corp Lysosomal Alpha Glucosidase Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Genzyme Corp Lysosomal Alpha Glucosidase Product Portfolio
  42. 8.7.5 Genzyme Corp Recent Developments
  43. 8.8 Etubics Corp
  44. 8.8.1 Etubics Corp Company Information
  45. 8.8.2 Etubics Corp Business Overview
  46. 8.8.3 Etubics Corp Lysosomal Alpha Glucosidase Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Etubics Corp Lysosomal Alpha Glucosidase Product Portfolio
  48. 8.8.5 Etubics Corp Recent Developments
  49. 8.9 Audentes Therapeutics Inc
  50. 8.9.1 Audentes Therapeutics Inc Company Information
  51. 8.9.2 Audentes Therapeutics Inc Business Overview
  52. 8.9.3 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
  54. 8.9.5 Audentes Therapeutics Inc Recent Developments
  55. 8.10 Amicus Therapeutics Inc
  56. 8.10.1 Amicus Therapeutics Inc Company Information
  57. 8.10.2 Amicus Therapeutics Inc Business Overview
  58. 8.10.3 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
  60. 8.10.5 Amicus Therapeutics Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lysosomal Alpha Glucosidase Value Chain Analysis
  2. 9.1.1 Lysosomal Alpha Glucosidase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lysosomal Alpha Glucosidase Sales Mode & Process
  6. 9.2 Lysosomal Alpha Glucosidase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lysosomal Alpha Glucosidase Distributors
  9. 9.2.3 Lysosomal Alpha Glucosidase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst